Pilot of oral Sildenafil for the treatment of Pulmonary Hypertension in Thalassaemia with comparison to controls

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-016096-29

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate whether 12 weeks of treatment with oral sildenafil increases Six Minute Walk Time (6MWT) distance in thalassaemia patients with Pulmonary Hypertension (PHT). Hypothesis: Mean twelve-week change in 6MWT distance will be greater than +60m in thalassaemia patients with PHT treated with oral sildenafil.


Critère d'inclusion

  • Pulmonary Hypertension in Thalassaemia patients

Liens